Edition:
United Kingdom

People: Sartorius Stedim Biotech SA (STDM.PA)

STDM.PA on Paris Stock Exchange

128.20EUR
3:40pm BST
Change (% chg)

€-0.20 (-0.16%)
Prev Close
€128.40
Open
€127.90
Day's High
€129.10
Day's Low
€125.90
Volume
25,154
Avg. Vol
69,075
52-wk High
€150.70
52-wk Low
€79.65

Riey, Henri 

Mr. Henri Riey has served as Non-Executive Independent Director of Sartorius Stedim Biotech SA as of June 29, 2007. He is also Member of the Remuneration and Nominating Committee and since December 5, 2007 he has served as Chairman of Company's Audit Committee. Mr. Riey holds a degree from Institut Superieur de Gestion (ISG) and began his career as Fund Manager at BNP Paribas in 1985. In 1988, he joined Barclays in France as Fund Manager and Head of the European Securities Management team. He was subsequently appointed Director of Research of Barclays Asset Management Europe in 1996 and then Vice President of Barclays Asset Management in charge of all fund management activities in 1999. From 2004 to 2013, Mr. Riey was Director of Finance at Hendyplan S.A. He currently serves as President of Aidea, President of Group HR SAS as well as Traesurer and Secretary General of The Princess Grace Foundation in Monaco.

Basic Compensation

Total Annual Compensation, EUR 50,200
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 50,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --